<--- Back to Details
First PageDocument Content
Neuroimaging / Radiation oncology / Radiopharmaceuticals / Positron emission tomography / Radiopharmacology / Single-photon emission computed tomography / Radioactive tracer / Medicine / Radiobiology / Medical physics
Date: 2013-07-29 09:35:58
Neuroimaging
Radiation oncology
Radiopharmaceuticals
Positron emission tomography
Radiopharmacology
Single-photon emission computed tomography
Radioactive tracer
Medicine
Radiobiology
Medical physics

POSITRON EMISSION TOMOGRAPHY(PET) TECHNOLOGY AND APPLICATION 3-DAY COURSE KING’S COLLEGE LONDON Wednesday 9th – Friday 11th April 2014 You are invited to the ever popular 3-day course on

Add to Reading List

Source URL: radiomi.chem.ox.ac.uk

Download Document from Source Website

File Size: 171,55 KB

Share Document on Facebook

Similar Documents

What Is PET? Positron Emission Tomography (PET) is a non-invasive form of medical imaging approved by Medicare for diagnosis and management of several forms of cancer including: 	 Lung Cancer

What Is PET? Positron Emission Tomography (PET) is a non-invasive form of medical imaging approved by Medicare for diagnosis and management of several forms of cancer including: Lung Cancer

DocID: 1uv0l - View Document

Determining the diagnostic kinetics of viral encephalitis using positron emission tomography (PET) in Münster Nicholas King, Discipline of Pathology, Bosch Institute, School of Medical Sciences, Sydney Medical School, U

Determining the diagnostic kinetics of viral encephalitis using positron emission tomography (PET) in Münster Nicholas King, Discipline of Pathology, Bosch Institute, School of Medical Sciences, Sydney Medical School, U

DocID: 1rQ7R - View Document

Histopathologic Features that Influence the Detection of Occult Lymph Node Metastasis Using PET/CT Imaging with Anti-PSMA Df-IAB2M in Newly Diagnosed High Risk Prostate Cancer Patients. 89Zr-  Bernard M. Gburek1, Anthony

Histopathologic Features that Influence the Detection of Occult Lymph Node Metastasis Using PET/CT Imaging with Anti-PSMA Df-IAB2M in Newly Diagnosed High Risk Prostate Cancer Patients. 89Zr- Bernard M. Gburek1, Anthony

DocID: 1rqYg - View Document

THE U~VERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO

THE U~VERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO

DocID: 1riLo - View Document

Microsoft Word - 25-32_FINAL_SN0302.doc

Microsoft Word - 25-32_FINAL_SN0302.doc

DocID: 1rbdW - View Document